Catalio Capital Management, LPinsider trades
In SEC Form 4 filings, Catalio Capital Management, LP is listed as 10% owner of Iambic Therapeutics, Inc. (IAM). Catalio Capital Management, LP reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 19.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| IAMIambic Therapeutics, Inc. | 10% owner | 8 | Oct 19 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-19
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C | 1,995,749 | not reported | not reported | 1,995,749 | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C | 1,458,290 | not reported | not reported | 1,458,290 | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C | 742,546 | not reported | not reported | 742,546 | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 1,141,878 | $0.00 | $0 | not reported | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 731,187 | $0.00 | $0 | not reported | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 122,684 | $0.00 | $0 | not reported | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 1,458,290 | $0.00 | $0 | not reported | No | Form 4 |
| IAMIambic Therapeutics, Inc. | Oct 16 | Oct 19 | C · derivative | 742,546 | $0.00 | $0 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.